Lindsay Bahr, a Director at Alnylam Pharmaceuticals, drives market access for RNAi therapies. Her expertise ensures access to Alnylam’s innovative treatments. A leader in US HealthTech, Bahr aligns stakeholders to advance Alnylam’s mission: SILENCE DISEASE. AMPLIFY LIFE.
666 3rd Ave, 6th Floor, New York, NY 10017